Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
Using Shared Decision Making to Improve Family Media Use Planning
for
Adolescent Behavior
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 11+
Code: NCT05722535
Recruiting
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
for
Hypothalamic Obesity,
Location: Seattle WA, Aurora CO, Saint Paul MN, Chicago IL,
Sponsor: Rhythm Pharmaceuticals, Inc.
Sex: All
Age: 4+
Code: NCT06760546
Phase3, Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Seattle WA, Orange CA, Denver CO, Phoenix AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
for
Pulmonary Invasive Fungal Infections,
Location: Seattle WA, Portland OR, Palo Alto CA, Orange CA,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 21
Code: NCT03827694
Recruiting
Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment
for
Alcohol Use Disorder, Unhealthy Alcohol Use
Location: Seattle WA
Sponsor: Kaiser Permanente
Sex: All
Age: 18+
Code: NCT06318026
Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
for
Von Willebrand Disease (VWD),
Location: Seattle WA, Portland OR, Los Angeles CA, Phoenix AZ,
Sponsor: Hemab ApS
Sex: All
Age: 16+
Code: NCT06610201
Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Cabaletta Bio
Sex: All
Age: 6 - 70+
Code: NCT06154252
Phase2, Phase3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Bellevue WA, Silverdale WA, Spokane WA, Sacramento CA,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Bellevue WA, Silverdale WA, Springfield OR,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Bellevue WA, Silverdale WA, Springfield OR,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
for
Frontal Fibrosing Alopecia
Location: Bellevue WA
Sponsor: Bellevue Dermatology
Sex: All
Age: 18+
Code: NCT03422640
Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Bellevue WA, Spokane WA, Boise ID, Rapid City SD,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase3, Recruiting
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
for
Diabetes Mellitus, Type 1
Location: Seattle WA, Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 49
Code: NCT05819138
Phase3, Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
for
Neurotrophic Keratopathy
Location: Seatle WA, Portland OR, Medford OR, Loma Linda CA,
Sponsor: ReGenTree, LLC
Sex: All
Age: 18+
Code: NCT05555589
Phase3, Recruiting
ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)